Endoceutics, Inc.
- Country
- 🇧🇪Belgium
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.endoceutics.com
Clinical Trials
9
Trial Phases
1 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
- Conditions
- Vaginal Atrophy in Breast Cancer Patients
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- EndoCeutics Inc.
- Registration Number
- NCT03740945
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
- Conditions
- Hypoactive Sexual Desire Disorder (HSDD)
- Interventions
- Drug: Placebo Vaginal Insert
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- EndoCeutics Inc.
- Registration Number
- NCT03619005
- Locations
- 🇺🇸
Endoceutics site # 106, Huntsville, Alabama, United States
🇺🇸Endoceutics site # 17, San Diego, California, United States
🇺🇸Endoceutics site # 125, New London, Connecticut, United States
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo Vaginal Insert
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- EndoCeutics Inc.
- Target Recruit Count
- 653
- Registration Number
- NCT03287232
- Locations
- 🇺🇸
Endoceutics site # 106, Huntsville, Alabama, United States
🇺🇸Endoceutics site # 104, Mobile, Alabama, United States
🇺🇸Endoceutics site # 117, Tucson, Arizona, United States
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- EndoCeutics Inc.
- Target Recruit Count
- 558
- Registration Number
- NCT02013544
- Locations
- 🇺🇸
EndoCeutics site # 39, Montgomery, Alabama, United States
🇺🇸EndoCeutics site # 14, Tucson, Arizona, United States
🇺🇸EndoCeutics site # 21, Sacramento, California, United States
Topical DHEA Against Vaginal Atrophy
- Conditions
- Vaginal Atrophy
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- EndoCeutics Inc.
- Target Recruit Count
- 218
- Registration Number
- NCT01846442
- Locations
- 🇺🇸
EndoCeutics site # 05, Cleveland, Ohio, United States
🇺🇸EndoCeutics site # 03, Norfolk, Virginia, United States
🇨🇦EndoCeutics site # 10, Montreal, Quebec, Canada
- Prev
- 1
- 2
- Next